Terns Pharmaceuticals Correlations

TERN Stock

USD 5.79 0.08 1.40%

The current 90-days correlation between Terns Pharmaceuticals and Capricor Therapeutics is -0.11 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Terns Pharmaceuticals Correlation With Market

Average diversification

The correlation between Terns Pharmaceuticals and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.

Moving together with Terns Stock

0.77	ME	23Andme Holding	Pair Corr
0.63	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.77	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.73	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.65	GMAB	Genmab AS	Pair Corr
0.73	INZY	Inozyme Pharma	Pair Corr
0.62	MTEM	Molecular Templates	Pair Corr
0.81	NKTX	Nkarta Inc	Pair Corr
0.63	PHAT	Phathom Pharmaceuticals	Pair Corr

Moving against Terns Stock

0.71	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.59	EWTX	Edgewise Therapeutics	Pair Corr
0.59	KZR	Kezar Life Sciences	Pair Corr
0.49	GILD	Gilead Sciences	Pair Corr
0.37	KTTAW	Pasithea Therapeutics	Pair Corr
0.67	MNPR	Monopar Therapeutics	Pair Corr
0.65	RVMD	Revolution Medicines Sell-off Trend	Pair Corr
0.62	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.56	AKRO	Akero Therapeutics	Pair Corr
0.44	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.43	PLRX	Pliant Therapeutics	Pair Corr
0.41	MLYS	Mineralys Therapeutics,	Pair Corr
0.33	SRZN	Surrozen	Pair Corr

Related Correlations Analysis

	CAPR	AKTX	SLNO	BPTH	MBRX	CRNX	ASMB	TIL	CTMX	ACHL
CAPR		-0.78	0.66	0.01	0.25	0.65	-0.17	-0.02	-0.64	0.85	CAPR
AKTX	-0.78		-0.74	0.29	-0.41	-0.64	0.12	0.12	0.74	-0.76	AKTX
SLNO	0.66	-0.74		-0.04	0.08	0.78	0.19	-0.12	-0.6	0.55	SLNO
BPTH	0.01	0.29	-0.04		-0.33	0.05	0.25	-0.02	0.43	-0.27	BPTH
MBRX	0.25	-0.41	0.08	-0.33		0.12	-0.23	0.01	-0.35	0.38	MBRX
CRNX	0.65	-0.64	0.78	0.05	0.12		0.24	-0.27	-0.54	0.48	CRNX
ASMB	-0.17	0.12	0.19	0.25	-0.23	0.24		0.18	0.19	-0.2	ASMB
TIL	-0.02	0.12	-0.12	-0.02	0.01	-0.27	0.18		0.28	0.19	TIL
CTMX	-0.64	0.74	-0.6	0.43	-0.35	-0.54	0.19	0.28		-0.65	CTMX
ACHL	0.85	-0.76	0.55	-0.27	0.38	0.48	-0.2	0.19	-0.65		ACHL
	CAPR	AKTX	SLNO	BPTH	MBRX	CRNX	ASMB	TIL	CTMX	ACHL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ACHL	+ 0.85	CAPR
CRNX	+ 0.78	SLNO
CTMX	+ 0.74	AKTX
SLNO	+ 0.66	CAPR
CRNX	+ 0.65	CAPR
ACHL	+ 0.55	SLNO

High negative correlations

AKTX	- 0.78	CAPR
ACHL	- 0.76	AKTX
SLNO	- 0.74	AKTX
ACHL	- 0.65	CTMX
CRNX	- 0.64	AKTX
CTMX	- 0.64	CAPR

Risk-Adjusted Indicators

There is a big difference between Terns Stock performing well and Terns Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Terns Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CAPR	6.82	2.55	0.48	7.32	4.11	(9.61)	18.22	(7.37)	69.31
AKTX	4.13	(1.37)	0.00	2.77	0.00	0.00	4.84	(12.30)	47.27
SLNO	2.19	0.42	0.10	(1.29)	2.18	(2.52)	6.31	(4.03)	13.33
BPTH	4.05	(0.23)	0.00	0.34	0.00	0.00	6.67	(8.08)	51.22
MBRX	3.74	0.14	0.03	0.28	4.27	(4.59)	9.75	(7.01)	35.41
CRNX	1.73	0.12	(0.01)	(0.62)	2.47	(1.68)	3.67	(3.45)	16.75
ASMB	2.91	0.09	0.00	0.31	4.46	(2.82)	8.49	(5.34)	24.80
TIL	9.42	1.47	0.25	0.40	6.84	(12.97)	20.63	(10.89)	105.83
CTMX	2.58	(0.53)	0.00	(0.35)	0.00	0.00	5.00	(5.22)	20.61
ACHL	2.05	0.65	0.19	(2.26)	1.53	(3.28)	3.06	(2.88)	38.16

Terns Pharmaceuticals Corporate Management

David Strauss	VP Controller	Profile
Pamela Danagher	Senior Assurance	Profile
Debra Sieminski	Senior Affairs	Profile
Jeffrey Jasper	Senior Research	Profile
JD Esq	Chief Officer	Profile
Senthil Sundaram	CEO Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC